Displaying drugs 14876 - 14900 of 15780 in total
BMN-052
Experimental
Withdrawn
BMN-053
Experimental
Withdrawn
αAβ–Gas6
αAβ–Gas6 is a chimeric fusion protein being investigated in preclinical studies as an immunotherapeutic agent for Alzheimer's disease (AD). It is made of a single chain variable fragment (scFv) of an Amyloid β (Aβ)-targeting monoclonal antibody fused with a truncated receptor binding domain of growth arrest-specific 6 (Gas6), which is...
Experimental
Matched Description: … inducer of Aβ,[A253203] which is the main component of the amyloid plaques found in individuals with AD and …
Ontorpacept
Investigational
OSE-2101
Investigational
Roneparstat
Investigational
L-Leucyl-L-prolyl-L-prolyl-L-seryl-L-arginine
Investigational
Ad-RTS-hIL-12
Investigational
APVO-436
Investigational
XMMME-001-DTPA 111 Indium
Investigational
APC8020
Investigational
Vadacabtagene leraleucel
Investigational
MV-NB-02
Investigational
TPIV 200
TPIV 200 is a vaccine consisting of proteins from the folate receptor alpha mixed with Granulocyte-macrophage colony-stimulating factor (GM-CSF).
Investigational
Falimarev
Investigational
Indium In-111 altumomab pentetate
Investigational
MGN-4893
MGN-4893 is an inhibitor of microRNA-451. In February 2011, it was granted FDA orphan designation for the treatment of polycythemia vera.
Investigational
TNT-1
Investigational
BB 21217
BB 21217 is an anti-BCMA CAR T cell therapy that uses the same CAR molecule as idecabtagene vicleucel (bb2121), but adds the PI3K inhibitor bb007 during ex vivo culture to enrich the drug product (DP) for memory-like T cells.
Investigational
Vixtimotamab
Investigational
Belagenpumatucel-L (SK-LU-1)
Investigational
MRG-003
MRG-003 is a recombinant humanized anti-human epidermal growth factor receptor monoclonal antibody conjugated to monomethyl auristatin E.
Investigational
AAV-AQP1
Investigational
Deoxynucleogene ancparvovec
Investigational
AML-2-23
Investigational
Displaying drugs 14876 - 14900 of 15780 in total